Corporate Presentation

Summary and Future Catalysts 1st Mover Advantage Leader Extraction Only EU GMP Certification expected H2 2019 High Growth + Margin « First oil shipment to AusCann in Australia Scale ll Increasing dry cannabis supply Wholesale/Private label production and distribution agreements Revenue Expansion to 250,000 kg annual capacity expected by Q2 2019 $³ Canadian legalization of edibles & vapeables Fall 2019 creates another significant addressable market Predictable Cash Flow M&A and International Growth Opportunities Completion of Australian extraction facility M&A or JV opportunities MediPharm Labs | 13

View entire presentation